154 related articles for article (PubMed ID: 11813117)
21. Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years.
Son BH; Kwak BS; Kim JK; Kim HJ; Hong SJ; Lee JS; Hwang UK; Yoon HS; Ahn SH
Arch Surg; 2006 Feb; 141(2):155-60. PubMed ID: 16490892
[TBL] [Abstract][Full Text] [Related]
22. Frequency of asymptomatic choroidal metastasis in patients with disseminated breast cancer: results of a prospective screening programme.
Wiegel T; Kreusel KM; Bornfeld N; Bottke D; Stange M; Foerster MH; Hinkelbein W
Br J Ophthalmol; 1998 Oct; 82(10):1159-61. PubMed ID: 9924304
[TBL] [Abstract][Full Text] [Related]
23. Choroid metastases: clinical features and treatments in 123 patients.
d'Abbadie I; Arriagada R; Spielmann M; Lê MG
Cancer; 2003 Sep; 98(6):1232-8. PubMed ID: 12973847
[TBL] [Abstract][Full Text] [Related]
24. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.
Barnholtz-Sloan JS; Sloan AE; Davis FG; Vigneau FD; Lai P; Sawaya RE
J Clin Oncol; 2004 Jul; 22(14):2865-72. PubMed ID: 15254054
[TBL] [Abstract][Full Text] [Related]
25. Optical coherence tomography characteristics of choroidal metastasis.
Arevalo JF; Fernandez CF; Garcia RA
Ophthalmology; 2005 Sep; 112(9):1612-9. PubMed ID: 16039718
[TBL] [Abstract][Full Text] [Related]
26. [Change in the occurrence of breast cancer in hospital registries (1980-2000)].
Belicza M; Lenicek T; Glasnović M; Elez M; Gladić V; Marton I; Zuteković S; Jurlina H; Kusić Z; Cvrtila D; Strnad M; Tomas D; Cupić H; Kruslin B
Lijec Vjesn; 2002; 124(11-12):347-53. PubMed ID: 12679975
[TBL] [Abstract][Full Text] [Related]
27. Brain metastases in breast cancer: prognostic factors and management.
Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
[TBL] [Abstract][Full Text] [Related]
28. Clinical features of choroidal metastases from carcinoid tumour.
She H; Zheng Y; Wang X; Quan Y; Sun N
Yan Ke Xue Bao; 2004 Mar; 20(1):15-8. PubMed ID: 15124527
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
30. [Clinical features and prognosis of multiple primary tumors of lung combined with other organs--report of 281 cases].
Yi SZ; Zhang DC; Wang YG; Sun KL
Ai Zheng; 2006 Jun; 25(6):731-5. PubMed ID: 16764770
[TBL] [Abstract][Full Text] [Related]
31. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
32. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.
Lee PC; Port JL; Korst RJ; Liss Y; Meherally DN; Altorki NK
Ann Thorac Surg; 2007 Jul; 84(1):177-81. PubMed ID: 17588407
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for initial lung metastasis from breast invasive ductal carcinoma in stages I-III of operable patients.
Gao D; Du J; Cong L; Liu Q
Jpn J Clin Oncol; 2009 Feb; 39(2):97-104. PubMed ID: 19052036
[TBL] [Abstract][Full Text] [Related]
35. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
36. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
[TBL] [Abstract][Full Text] [Related]
37. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases.
Mihai R; Stevens J; McKinney C; Ibrahim NB
Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154
[TBL] [Abstract][Full Text] [Related]
38. Choroidal metastases 34 years after remission of breast cancer.
Randhawa S; Johnson RN
Retin Cases Brief Rep; 2015; 9(1):25-9. PubMed ID: 25383858
[TBL] [Abstract][Full Text] [Related]
39. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
Bensouda Y; André F; Boulet T; Al-Ghuzlan A; Conforti R; Troalen F; Bourgier C; Errihani H; Spielmann M; Delaloge S
Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005
[TBL] [Abstract][Full Text] [Related]
40. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy.
Er O; Frye DK; Kau SW; Broglio K; Valero V; Hortobagyi GN; Arun B
Cancer J; 2008; 14(1):62-8. PubMed ID: 18303485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
